Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications

Francisco Espinoza, Sylvie Fabre, Yves Marie Pers*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science